This finding may contribute in part to the explanation for why the combination of agonists targeting both the GIP and GLP-1 systems has yielded promising results in preclinical models and clinical trials, providing greater body weight loss and better glycemic control than GLP-1R agonism alone (25,5457)
Andrew: -efforts, and for coming here to do this significant public education effort about peptides and other compounds and regulatory bodies, and also just the field of medicine
Hagedorn, J
BPC 157 and Blood Vessels | Bentham Science Cushman CJ, et al
They help people lose weight by: Making you feel full faster and longer Reducing appetite and food cravings Lowering your preference for high-calorie foods Slowing digestion so you feel satisfied longer In clinical trials, people taking these medications lost significant amounts of weight
As Clinical Practice Development Director, Lee helps shape the RegenCen patient experience and provider training programs, ensuring the highest standards of care